New research shows that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood ...

This article is authored by Swati Kanodia, consultant pediatric endocrinologist, Madhukar Rainbow Children's Hospital.

Mounjaro shows promise for young patients with Type 2 diabetes and obesity. A recent study reveals its active ingredient, ...

Two new studies found that Type 2 diabetes appears to have doubled in children amid the COVID-19 pandemic. ABC News chief medical correspondent Dr. Jennifer Ashton broke down what's behind the recent ...

In children and adolescents with type 2 diabetes (T2D) or obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) ...

Eli Lilly and Company (NYSE: LLY) today announced detailed results from SURPASS-PEDS, the first Phase 3 trial to evaluate the safety and efficacy of Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor ...

Although type 2 diabetes is often regarded as a disease of ageing, cases of type 2 diabetes in children and adolescents have ...

New research shows that that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood sugar control and weight loss in children and adolescents with type 2 ...

Experts say the condition—formally known as latent autoimmune diabetes in adults—can result in health complications if it isn ...

Diabetes is one of the most common health issues today, affecting millions of people worldwide. It happens when the body can’t properly regulate blood sugar. Type 1 diabetes is usually genetic and ...

Two new studies looked at diseases exacerbated by stay-at-home orders. Two new studies found that Type 2 diabetes appears to have doubled in children amid the COVID-19 pandemic. ABC News chief medical ...